Drug-induced non-palpable purpura in Adult
Alerts and Notices
Important News & Links
Synopsis
Uncommonly, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been associated with purpuric skin lesions on the lower extremities, including purpuric macules or papules with confluent plaques, sometimes in an annular configuration; non-follicular purpuric pustules; and xerotic purpuric lesions. See also EGFR inhibitor-induced eruption.
Drug-induced thrombotic thrombocytopenic purpura (TTP) may occur secondary to medication use. It is a life-threatening, multisystem disease. There is strong literature evidence of ticlopidine as a trigger of TTP. Other triggers of TTP frequently reported include interferon alpha (IFN-alpha) therapy, cyclosporine, quinine, and clopidogrel.
Codes
L27.1 – Localized skin eruption due to drugs and medicaments taken internally
SNOMEDCT:
109957002 – Drug-induced purpura
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Subscription Required
References
Subscription Required